Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nintedanib

EU orphan designation number: EU/3/16/1724   
Active ingredient: Nintedanib
Indication: Treatment of systemic sclerosis
Sponsor: Boehringer Ingelheim International GmbH
Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/095/16 (2016)5631 of 29/08/2016